Prevention

A recent WHO news release reports that infant immunization rates continue to fall short of the global immunization target of 90%.

Arjun Srinivasan, MD, stresses the importance of surgical teams speaking up if they have safety concerns regarding procedure in operating rooms.

Jason Pogue, PharmD, BCPS-ID, explains his team’s study regarding the susceptibility of Pseudomonas isolates to ceftolozane/tazobactam.

Milena McLaughlin, PharmD, MSc, explains the best way to determine an alternative agent during a drug shortage.

Outbreaks of measles have resulted in over 14,000 infections and the loss of 35 lives across Europe since January 2016.

Caetano Sabino, BSc, discusses how antimicrobial photodynamic therapy could be used to complement antimicrobial chemotherapy in order to manage drug-resistant infections.

Although the yellow fever outbreak that has affected several Latin American countries has eased since the end of summer, health officials say new cases are still springing up in some areas.

The new Senate healthcare bill released last week has died on the vine, even before it was formally put forward for deliberation and vote.

Ebola virus tracking and mechanisms to detect threats to our national food supply are highlighted.

Jason Gallagher, PharmD, BCPS, FCCP, FIDSA, explains how restrictions on commercial automated susceptibility testing can affect patient care.

Researchers from the Maryland Department of Health and Mental Hygiene have found that pet owners are at increased risk of encountering ticks.

A research team from the Netherlands turns to deep sequencing technology to detect hepatitis C virus resistant variants.

The results of a new study reinforce the importance of performing stethoscope hygiene.

Snigdha Vallabhaneni, MD, MPH, recommends ways for caretakers to protect themselves from acquiring Candida auris.

A team of investigators are dedicating their efforts to pinpointing a source of the E. coli outbreak that has sprung up on the Utah-Arizona border.

The results of a new study have revealed that that classic “beads on a string” model of the influenza A virus may not be entirely accurate.

A new study published by the Centers for Disease Control and Prevention indicates that patients receiving eculizumab can still contract meningitis, even if they have been vaccinated.

Kenneth Mayer, MD, discusses new therapies that may have a positive impact on pre-exposure prophylaxis adherence and treatment.

A new iteration of the American Health Care Act (AHCA), the challenge of sepsis in US hospitals, a predictive map that identifies which species are likely to harbor the next human virus, how one Canadian researcher mail-ordered his way to horsepox, and a focus on how gonorrhea is on the way to becoming untreatable comprise the top 5 articles of the week for the week.

A new report from the National Center for Health Statistics has found that too many adults aged 65 and older are missing out on important vaccinations.

New research suggests that a vaccine designed to protect against meningitis may also protect against gonorrhea infections.

Caetano P. Sabino, BSc, PhD Student, explains if photodynamic therapy a cost-effective treatment option.

Senate Majority Leader Mitch McConnell and his Republican colleagues have written and released a new version of the American Health Care Act (AHCA) that addresses many outstanding concerns, but will it be enough?

Meghan Jeffres, PharmD, explains the importance of discussing cross-reactivity among beta-lactams.

For the most challenging of microbial threats, one microbiologist is trying an old tactic in a new era.

Cases of antibiotic-resistant gonorrhea are on the rise, and the bacteria may soon become untreatable if new antibiotics and diagnostic tools are not developed.

Researchers from the University of Pittsburgh find a way to successfully treat a patient with ceftazidime-avibactam-resistant Klebsiella pneumoniae.

Milena McLaughlin, PharmD, MSc, explains different strategies institutions can take to obtain antimicrobials that are on shortage.

A Canadian researcher recently built horsepox from mail-ordered DNA and with it comes an extra delivery of dual-use scrutiny.